Horizon Texofab Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
as on 24-10-2024
- Paid Up Capital ₹ 0.70 M
as on 24-10-2024
- Company Age 14 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Revenue -4.18%
(FY 2023)
- Profit 20.15%
(FY 2023)
- Ebitda 2.66%
(FY 2023)
- Net Worth 2.07%
(FY 2023)
- Total Assets 63.20%
(FY 2023)
About Horizon Texofab
The Company is engaged in the Home & Lifestyle Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 0.70 M, as per Ministry of Corporate Affairs (MCA) records.
Sangeeta Grover and Prem Grover serve as directors at the Company.
- CIN/LLPIN
U17290DL2010PTC202537
- Company No.
202537
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
12 May 2010
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Horizon Texofab?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sangeeta Grover  | Director | 12-May-2010 | Current |
| Prem Grover | Director | 01-Sep-2012 | Current |
Financial Performance of Horizon Texofab.
Horizon Texofab Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 4.18% decrease. The company also saw a substantial improvement in profitability, with a 20.15% increase in profit. The company's net worth moved up by a moderate rise of 2.07%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Horizon Texofab?
In 2023, Horizon Texofab had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Panipat Investment And Financial Services Private LimitedActive 29 years 9 monthsSangeeta Grover and Prem Grover are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Horizon Texofab?
Unlock and access historical data on people associated with Horizon Texofab, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Horizon Texofab, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Horizon Texofab's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
